Navigation Links
Sanofi-aventis Announces Second Quarter 2009 Results
Date:7/29/2009

es business excluding H5N1 contracts(2)

  • Net sales growth of 5.4% in the U.S., 4.6% in Europe and 20.1% in Emerging Markets

  • Multaq(R): approved by the FDA on July 1, and launched in the United States on July 28

2009 Results and Guidance

  • 2009 second-quarter growth of adjusted EPS excluding selected items of 17.2% at constant exchange rates and 29.9% on a reported basis

  • Strong cash flow from operating activities in the first half, at euro 4,378 million

  • Guidance raised: growth in adjusted EPS excluding selected items of around 10% at constant exchange rates, barring major adverse events

(1) Growth in net sales is expressed at constant exchange rates unless otherwise indicated; (2) $192.5 million in Q2 2008 vs $32.5 million in Q2 2009

Transformation of sanofi-aventis

  • Increasing innovation in R&D: launch of a new R&D approach; start of Phase III for BSI-201 in triple negative breast cancer; license and collaboration agreement with Exelixis
  • Exploring external growth opportunities: significant boost to our Vaccines business in Emerging Markets with the acquisition(3) of Shantha Biotechnics in India; Generics business more than tripled in size with the integration of Zentiva, Medley and Kendrick
  • Adapting our structures to meet the challenges of the future: Target of euro 2 billion of recurring cost savings by 2013

Commenting on the Group's 2009 second quarter results, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said:

"The group delivered very strong results in the second quarter, driven b
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
4. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
5. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
6. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
7. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
8. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
9. Sanofi-aventis U.S. Announces Settlement of Medicaid Best Price Investigation
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... April 22 OmniComm Systems, Inc. (OTC Bulletin Board: ... clinical trials market today announced its results of operations ... first quarter of 2009 increased approximately 139% to $2,416,600 ... Gross profit margin improved to 79.5% for the three ...
... NEW YORK, April 23 Government and private insurers ... demonstrate value for the products they develop, according to ... sciences. Insurers, governments and individuals are likely to increase ... they confront mounting healthcare costs, a shrinking tax base, ...
... CAMBRIDGE, Mass., April 23 Idenix Pharmaceuticals, Inc. (Nasdaq: ... the discovery and development of drugs for the treatment ... three hepatitis C development programs being presented this week ... for the Study of the Liver (EASL) in Copenhagen, ...
Cached Biology Technology:OmniComm Systems Announces 1st Quarter Results of Operations 2OmniComm Systems Announces 1st Quarter Results of Operations 3Failing to Demonstrate Value of Innovation is Top Risk Facing Life Sciences Sector, According to Ernst & Young 2Failing to Demonstrate Value of Innovation is Top Risk Facing Life Sciences Sector, According to Ernst & Young 3Failing to Demonstrate Value of Innovation is Top Risk Facing Life Sciences Sector, According to Ernst & Young 4Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver 2Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver 3Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver 4Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver 5
(Date:4/15/2014)... Md., is home to hundreds of dedicated scientists, ... of the most cutting-edge Earth science innovation and ... innovation has earned a Goddard scientist the 2014 ... and Geography awards the Vega Medal every three ... in the fields of physical geography, exploration or ...
(Date:4/15/2014)... mother-child pairs, researchers from the Bloomberg School of ... serotonin reuptake inhibitors (SSRIs), a frequently prescribed treatment ... with autism spectrum disorder (ASD) and developmental delays ... online edition of Pediatrics , analyzed data ... and population-based controls, where a uniform protocol was ...
(Date:4/15/2014)... Mo. University of Missouri researchers have previously shown ... motivated to exercise exists. In a new study, Frank ... Medicine, has found a potential link between the genetic ... speed at which mental maturation occurs. , For his ... either extreme activity or extreme laziness. Booth then put ...
Breaking Biology News(10 mins):Goddard scientist receives Vega Medal from King of Sweden 2Study: SSRI use during pregnancy associated with autism and developmental delays in boys 2Genetic pre-disposition toward exercise and mental development may be linked 2
... new evidence suggesting factors other than genes could cause ... amounts of fat depending on subtle variations in how ... for fat storage in cells could lead to methods ... will be important for understanding the precise roles of ...
... shows that human teeth lost some enamel hardness after the ... whiten teeth. The study suggests that future generations of such ... side effects. The researchers noted that teeth typically can ... calcification. But this is the first study to show at ...
... scientists have isolated the parasite Nosema ceranae ... depopulation syndrome. They then went on to treat the ... in the new journal from the Society for Applied ... analysed two apiaries and found evidence of honey bee ...
Cached Biology News:Findings show insulin -- not genes -- linked to obesity 2Findings show insulin -- not genes -- linked to obesity 3Home tooth bleaching slightly reduces enamel strength 2Home tooth bleaching slightly reduces enamel strength 3A cure for honey bee colony collapse? 2
... combines a single-channel sample processing head, an ... reagent dispenser all in one compact, affordable ... pipette tips, the Precision XS autoclavable and ... available for transferring larger volumes. Intuitive Precision ...
... races ever faster, you need a partner who ... our constant focus is on providing tools and ... our Biomek 3000 Laboratory Automation Workstation offers a ... is flexible. By integrating all aspects of liquid ...
... Rabbit Tissue Arrays contain 60 rabbit tissue samples ... contains 4 unstained slides and 1 hematoxylin and ... slide contains 15 different tissues from 4 rabbit ... per slide. Each tissue sample (or core) is ...
... with a wide variety of purity levels, scales ... Purity: IG(>50%), >70%, >80% and ... Sequence Length: Up to 120 residues ... D-amino acids, MAPs, KLH/BSA conjugation, and much more. ...
Biology Products: